AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KJUL 286 min read$MIR

Mirion Technologies, Inc. (MIR): Results of Operations and Financial Condition

Mirion Technologies, Inc. (MIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026-07x28exhibit991.htm EX-99.1 Document Exhibit 99.1 News Release Mirion Announces Second Quarter 2026 Financial Results • Revenues for the second quarter increased 19.7% to $266.8 million, compared to $222.9 million in the same period in 2025. • GAAP net income was

Original reporting
SEC EDGAR 8-K
Published Jul 28, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$MIR
Bullish
medium confidence
Mentioned
$MIR
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MIRBullishMed
01

Why it matters

The key tradable elements are the Q2 operating/cash metrics (adjusted EBITDA, adjusted free cash flow) and the reaffirmed 2026 guidance ranges, which together update the market’s earnings and cash-flow expectations.

02

Market read

Investors get a fresh quarterly datapoint set plus explicit 2026 guidance ranges, which can drive near-term re-rating and positioning ahead of the scheduled earnings call.

03

What to watch

The release notes Medical segment end-market composition adjustments; traders may want to watch whether that mix change affects margin sustainability or order quality into 2H 2026.

Relevance 7/10Novelty 7/10Timing: after-hours/filing today, ahead of the July 29, 2026 earnings call

Background

This is an SEC 8-K with Exhibit 99.1 covering Mirion’s Q2 2026 results and full-year 2026 guidance reaffirmation.

Company-level read

Ticker impact

$MIRBullishMedium confidence
Context

Mirion reported Q2 2026 revenue up 19.7% to $266.8M, with adjusted EBITDA up 27.5% to $65.3M, and reaffirmed full-year 2026 guidance.

Expected impact

Likely modest positive bias for the next session as traders digest the beat on adjusted EBITDA and the reaffirmed 2026 outlook.

Evidence & confidence

The filing provides concrete quarterly datapoints (revenue, GAAP/adjusted EPS, adjusted EBITDA, orders) plus explicit guidance ranges that are reaffirmed, which typically drives earnings-model updates even without a guidance raise.

Market effects

Sector

Reinforces demand momentum in radiation detection and nuclear-related monitoring, potentially supporting sentiment for defense and nuclear-adjacent instrumentation peers.

Regional

No specific regional shock; commentary emphasizes North America nuclear power opportunities and international growth ambitions.

Global

Guidance includes foreign exchange and acquisition tailwinds, so FX moves could matter for reported results versus organic growth.

Counterpoint

What could challenge this read

Organic revenue growth is only guided at 5% to 7%, so the stock may be sensitive if investors expected stronger underlying demand beyond acquisition and FX tailwinds.

Key entities

  • company
    Mirion Technologies, Inc.

    NYSE-listed radiation detection and monitoring solutions provider reporting Q2 2026 results and reaffirming 2026 guidance.

  • corporate_actions
    Certrec and Paragon acquisitions

    Acquisitions referenced as augmenting order growth and nuclear power opportunity capture.

Read at source← All news

Related articles

JUL 29
$MIRMed

MIR Q2 Deep Dive: Margin Expansion and Nuclear Backlog Growth Offset Revenue Miss

Mirion (NYSE: MIR) reported Q2 CY2026 revenue of $266.8 million, up 19.7% year over year but slightly below analysts’ $269.6 million estimate. Non-GAAP EPS was $0.12, above the $0.10 consensus, and adjusted EBITDA was $65.3 million. Management reiterated full-year Adjusted EPS guidance of $0.52 and EBITDA guidance of $292.5 million at the midpoint, citing margin expansion and nuclear backlog growth.

financialcontent.com6 min
JUL 6
$CEGMed

Microreactors Reach Milestones and Retailers Go Nuclear

Deployable Energy’s Unity microreactor reached criticality at Idaho National Laboratory, completing the third advanced reactor demonstration under a U.S. presidential executive order targeting three reactors by July 4, 2026. Constellation Energy (CEG) signed a long-term power purchase agreement with Walmart (WMT) for ~176 MW from Illinois’ Dresden Clean Energy Center, including uprate support.

etftrends.com5 min
AUG 8
$INBKMedAI 8/10

First Internet Bancorp (INBK) Q2 2026 Earnings Call Transcript

First Internet Bancorp (INBK) reported Q2 2026 revenue of $41.1 million, up 23%, and non-GAAP diluted EPS of $0.27 versus $0.02 a year earlier. Net interest margin (FTE) rose to 2.47%. Credit costs eased, but net charge-offs were $16.9 million. Full-year 2026 EPS guidance is $2.35 to $2.45.

fool.com7 min
AUG 8
$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

yahoo.com5 min
AUG 8
$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

yahoo.com6 min